ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$60.64M
Total Shares
830.2K
Net Share Change
+84.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$60.64M830.2K shares
ADD+84.1K(+11.3%)